India  

Central Drugs Standard Control Organisation

Indian Apex Drug Regulatory Body

Central Drugs Standard Control Organisation    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Central Drugs Standard Control Organisation: Indian Apex Drug Regulatory Body
The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory body for cosmetics, pharmaceuticals and medical devices. It serves a similar function to the Food and Drug Administration (FDA) of the United States or the European Medicines Agency of the European Union. The Indian government has announced its plan to bring all medical devices, including implants and contraceptives under a review of the Central Drugs and Standard Control Organisation (CDSCO).

0
shares
ShareTweetSavePostSend
 

You Might Like


Bring health supplements under drug control watch, suggests panel

An inter-ministerial committee has recommended that health supplements claiming to cure or mitigate diseases be classified as drugs. This shift aims to increase regulatory oversight by bringing these..
IndiaTimes - Published

Centre's lens on unapproved antibiotic combos, asks states to monitor availability

Centre requests states for licensed antibiotics. Study finds banned drugs still sold, with sales rising. Pharma firms promote new components to bypass rules, impacting resistance. CDSCO banned 26..
IndiaTimes - Published

Astra Zeneca gets nod for anticoagulant drug

AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organisation for the import and marketing of Andexanet Alfa. The therapy addresses..
IndiaTimes - Published

AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer


IndiaTimes - Published

World's first intranasal Covid vaccine from Bharat Biotech gets CDSCO approval

iNCOVACC: Bharat Biotech said that launch dates, pricing and availability will be announced in due course of time.
DNA - Published

Bharat Biotech's intranasal Covid-19 vaccine iNCOVACC gets CDSCO nod for heterologous booster doses


IndiaTimes - Published

Deaths in Gambia due to India-made cough syrups: Centre takes steps to curb damage, Haryana firm remains non-operational

Central Drugs Standard Control Organisation (CDSCO) launched an inquiry and alerted Haryana last week after learning about the Gambia tragedy.
DNA - Published

Firm behind Gambia child deaths a repeat offender in India

The Central Drug Standard Control Organisation (CDSCO) has been quick to assure people that the cough syrup which killed 66 children in Gambia was not being sold locally in India, but the same company,..
IndiaTimes - Published

Drug regulator launches probe on WHO alert over deaths in Gambia linked to India-made cough syrups: Report

The CDSCO said it responded to the WHO within an hour-and-a-half after receiving intimation.
DNA - Published

CDSCO grants EUA to Bharat Bio's intranasal Covid-19 vaccine

The Central Drugs Standard Control Organisation (CDSCO) has granted approval to BBV154 for restricted use in emergency situation, Union health minister Dr Mansukh Mandaviya announced via a tweet on..
IndiaTimes - Published

Zenara Pharma gets CDSCO nod to manufacture Covid drug


IndiaTimes - Published

Hyd-based Zenara Pharma gets CDSCO nod to make generic version of Pfizer's Covid-19 pill


IndiaTimes - Published

Biocon executive among 5 held in 'bribery' case

The CBI on Tuesday arrested three persons including L Praveen Kumar, associate vice president and head-national regulatory affairs of Bengaluru-based Biocon Biologics Limited, a company founded by..
IndiaTimes - Published

Expert panel recommends Corbevax Covid jab for 5-12 years age group

Biological Eā€™s Covid-19 vaccine, Corbevax, is likely to get an emergency-use authorisation (EUA) for use in children in the 5-12 years age bracket following recommendations from the subject expert..
IndiaTimes - Published